2-(3-Fluoro-4-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 25g

Leptomycin B, Streptomyces sp. ATS1287, 95%, 10mg

4-FLUORO-1-NITRO-2-(2,2,2-TRIFLUOROETHOXY)BENZENE, 95%, 100mg

6-ETHYLNICOTINIC ACID, 95.0%, 10g

delta-Valerolactam, 98.0%, 100g

2-Fluoro-3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 5g

1-Phenylbuta-2,3-dien-1-one, 97%, 10g

5-Fluoro-2-nitrophenylacetic acid, 97.0%, 5g

3,5-Dimethyl-4-nitro-1H-pyrrole-2-carbaldehyde, 95.0%, 100mg

3,3-Difluorohexanoic acid ethyl ester (stabilised over Potassium Carbonate), 5g

[2-(pyridin-4-yl)phenyl]methanamine, 95%, 500mg

4-Bromo-3-(hydroxymethyl)benzonitrile, 95.0%, 1g

N-(azetidin-3-yl)pyrazin-2-amine dihydrochloride, 95.0%, 250mg